Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia

PHASE2TerminatedINTERVENTIONAL

Enrollment

135

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions

Hospital-Acquired PneumoniaVentilator-Associated PneumoniaHealth-Care-Associated Pneumonia

Interventions

DRUG

iclaprim

DRUG

vancomycin